Evaluation of Selective COX-2 Inhibition and In Silico Study of Kuwanon Derivatives Isolated from Morus alba

被引:20
|
作者
Baek, Seung-Hwa [1 ,2 ]
Hwang, Sungbo [1 ]
Park, Tamina [1 ,3 ]
Kwon, Yoon-Ju [4 ]
Cho, Myounglae [4 ]
Park, Daeui [1 ,2 ,3 ]
机构
[1] Korea Inst Toxicol, Dept Predict Toxicol, Daejeon 34114, South Korea
[2] Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon 34114, South Korea
[3] Univ Sci & Technol, Dept Human & Environm Toxicol, Daejeon 34113, South Korea
[4] Natl Inst Korean Med Dev, Gyongsan 38540, South Korea
基金
新加坡国家研究基金会;
关键词
kuwanon A; cyclooxygenase inhibition assay; docking simulation; quantum mechanics;
D O I
10.3390/ijms22073659
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Six kuwanon derivatives (A/B/C/E/H/J) extracted from the roots of Morus alba L. were evaluated to determine their cyclooxygenase (COX)-1 and 2 inhibitory effects. Cyclooxygenase (COX) is known as the target enzyme of nonsteroidal anti-inflammatory drugs (NSAIDs), which are the most widely used therapeutic agents for pain and inflammation. Among six kuwanon derivatives, kuwanon A showed selective COX-2 inhibitory activity, almost equivalent to that of celecoxib, a known COX inhibitor. Kuwanon A showed high COX-2 inhibitory activity (IC50 = 14 mu M) and a selectivity index (SI) range of >7.1, comparable to celecoxib (SI > 6.3). To understand the mechanisms underlying this effect, we performed docking simulations, fragment molecular orbital (FMO) calculations, and pair interaction energy decomposition analysis (PIEDA) at the quantum-mechanical level. As a result, kuwanon A had the strongest interaction with Arg120 and Tyr355 at the gate of the COX active site (-7.044 kcal/mol) and with Val89 in the membrane-binding domain (-6.599 kcal/mol). In addition, kuwanon A closely bound to Val89, His90, and Ser119, which are residues at the entrance and exit routes of the COX active site (4.329 angstrom). FMO calculations and PIEDA well supported the COX-2 selective inhibitory action of kuwanon A. It showed that the simulation and modeling results and experimental evidence were consistent.
引用
下载
收藏
页数:13
相关论文
共 50 条
  • [1] Selective COX-2 inhibition
    Silas, S
    Clegg, DO
    BULLETIN ON THE RHEUMATIC DISEASES, 1999, 48 (02) : 1 - 4
  • [2] Synthesis and Evaluation of Benzimidazole Derivatives as Selective COX-2 Inhibitors
    Rathore, Ankita
    Mujeeb-Ur-Rahman
    Siddiqui, Anees A.
    Ali, Abuzer
    Yar, Mohammad Shahar
    MEDICINAL CHEMISTRY, 2015, 11 (02) : 188 - 199
  • [3] The pharmacology of selective inhibition of COX-2
    Grosser, Tilo
    THROMBOSIS AND HAEMOSTASIS, 2006, 96 (04) : 393 - 400
  • [4] Cardiovascular effects of selective COX-2 inhibition: Is there a class effect? The international COX-2 study group
    Crofford, Leslie J.
    Breyer, Matthew D.
    Strand, C. Vibeke
    Rushitzka, Frank
    Brune, Kay
    Farkouh, Michael E.
    Simon, Lee S.
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (07) : 1403 - 1408
  • [5] Determinants for the selective inhibition of COX-2 by lumiracoxib
    Blobaum, Anna L.
    Marnett, Lawrence J.
    DRUG METABOLISM REVIEWS, 2006, 38 : 121 - 122
  • [6] Selective COX-2 inhibition using Rofecoxib
    不详
    ORTHOPADE, 2000, 29 (02): : 1 - 4
  • [7] Synthesis and biological evaluation of ester derivatives of indomethacin as selective COX-2 inhibitors
    M. Arockia Babu
    Rakesh Shukla
    Chandishwar Nath
    S. G. Kaskhedikar
    Medicinal Chemistry Research, 2012, 21 : 2223 - 2228
  • [8] Synthesis and biological evaluation of resveratrol amide derivatives as selective COX-2 inhibitors
    Xin, Min
    Wu, Haoyu
    Du, Yuan
    Liu, Sheng
    Zhao, Feng
    Mou, Xiaofeng
    CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 380
  • [9] Synthesis and biological evaluation of ester derivatives of indomethacin as selective COX-2 inhibitors
    Babu, M. Arockia
    Shukla, Rakesh
    Nath, Chandishwar
    Kaskhedikar, S. G.
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (09) : 2223 - 2228
  • [10] A novel genetic model of selective COX-2 inhibition: Comparison with COX-2 null mice
    Yu, Ying
    Funk, Colin D.
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2007, 82 (1-4) : 77 - 84